Evidence map›Paper›PMID 26808569›Full record

ArticleBone marrow transplantation2016

Reduced intensity conditioning regimen with fludarabine, cyclophosphamide, low dose TBI and alemtuzumab leading to successful unrelated umbilical cord stem cell engraftment and survival in two children with dyskeratosis congenita.

M Brown, D Myers, N Shreve, R Rahmetullah, M Radhi

Open access · bronzeAbstract readCase Reports
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

M BrownDepartment of Pediatrics, University of Missouri Kansas City-School of Medicine, Kansas City, MO, USA.
D MyersDepartment of Pediatrics, Children's Mercy Hospital, Kansas City, MO, USA.
N ShreveDepartment of Pediatrics, Children's Mercy Hospital, Kansas City, MO, USA.
R RahmetullahDepartment of Pediatrics, Children's Mercy Hospital, Kansas City, MO, USA.
M RadhiDepartment of Pediatrics, Children's Mercy Hospital, Kansas City, MO, USA.
Children's Mercy Hospital · USUniversity of Missouri–Kansas City · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cord Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationAlemtuzumabBone MarrowChildCyclophosphamideDyskeratosis CongenitaGraft SurvivalHeterozygoteHumansImmunosuppressive AgentsMaleMutationTransplantation ConditioningVidarabineWhole Body ImagingAlemtuzumabCyclophosphamidefludarabineImmunosuppressive AgentsVidarabine

Identifiers

PMID26808569
OpenAlexW2346766270

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.